Post-GLP-1 Weight Loss Spurs Surge in Body Contouring Demand

The American Society of Plastic Surgeons reported that over 800,000 aesthetic patients utilized GLP-1 drugs last year, with a substantial portion either having undergone or currently considering surgical intervention. Dr. Stephen J. Ronan, founder of Blackhawk Plastic Surgery & MedSpa, describes the phenomenon as a positive consequence of successful dieting. Patients who have dropped extreme amounts of weight often find themselves managing excess tissue that no longer conforms to their new frames.

At the Danville clinic, the increased demand centers on corrective procedures including tummy tucks, arm lifts, thigh lifts, and lower body lifts. Beyond the torso, patients frequently seek facial rejuvenation. Dr. Ronan attributes facial volume loss not to the medications themselves—often dubbed "Ozempic face" on social media—but to the accelerated impact of rapid weight loss on natural aging processes. He suggests that patients stabilize their weight before pursuing surgical correction and stresses the importance of selecting board-certified surgeons at accredited facilities to ensure safety during these transformative procedures.